Logo image of AILE

ILEARNINGENGINES INC (AILE) Stock Fundamental Analysis

NASDAQ:AILE - Nasdaq - US45175Q1067 - Common Stock - Currency: USD

0.42  -0.29 (-40.59%)

After market: 0.315 -0.1 (-25%)

Fundamental Rating

2

AILE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. AILE may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, AILE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

AILE had negative earnings in the past year.
In the past year AILE has reported a negative cash flow from operations.
AILE Yearly Net Income VS EBIT VS OCF VS FCFAILE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 10M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -219.50%, AILE is doing worse than 96.79% of the companies in the same industry.
With a Return On Equity value of -11766.01%, AILE is not doing good in the industry: 89.29% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -219.5%
ROE -11766.01%
ROIC N/A
ROA(3y)6.68%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AILE Yearly ROA, ROE, ROICAILE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 20 -20 -40 -60

1.3 Margins

AILE has a Gross Margin of 76.68%. This is in the better half of the industry: AILE outperforms 71.43% of its industry peers.
AILE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AILE Yearly Profit, Operating, Gross MarginsAILE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 20 40 60

3

2. Health

2.1 Basic Checks

AILE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AILE has about the same amount of shares outstanding.
Compared to 1 year ago, AILE has a worse debt to assets ratio.
AILE Yearly Shares OutstandingAILE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M 100M
AILE Yearly Total Debt VS Total AssetsAILE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

AILE has an Altman-Z score of -1.68. This is a bad value and indicates that AILE is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.68, AILE is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
AILE has a Debt/Equity ratio of 20.27. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of AILE (20.27) is worse than 88.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 20.27
Debt/FCF N/A
Altman-Z -1.68
ROIC/WACCN/A
WACC11.22%
AILE Yearly LT Debt VS Equity VS FCFAILE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 3.40 indicates that AILE has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.40, AILE is doing good in the industry, outperforming 78.93% of the companies in the same industry.
A Quick Ratio of 3.40 indicates that AILE has no problem at all paying its short term obligations.
With a decent Quick ratio value of 3.40, AILE is doing good in the industry, outperforming 78.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.4
Quick Ratio 3.4
AILE Yearly Current Assets VS Current LiabilitesAILE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 20M 40M 60M 80M

4

3. Growth

3.1 Past

The earnings per share for AILE have decreased strongly by -138.43% in the last year.
Looking at the last year, AILE shows a very strong growth in Revenue. The Revenue has grown by 36.04%.
EPS 1Y (TTM)-138.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-381.07%
Revenue 1Y (TTM)36.04%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, AILE will show a very strong growth in Earnings Per Share. The EPS will grow by 120.68% on average per year.
AILE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 27.23% yearly.
EPS Next Y-3773.81%
EPS Next 2Y189.9%
EPS Next 3Y120.68%
EPS Next 5YN/A
Revenue Next Year32.01%
Revenue Next 2Y28.81%
Revenue Next 3Y27.23%
Revenue Next 5YN/A

3.3 Evolution

AILE Yearly Revenue VS EstimatesAILE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
AILE Yearly EPS VS EstimatesAILE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -0.5 -1

3

4. Valuation

4.1 Price/Earnings Ratio

AILE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 2.01, which indicates a rather cheap valuation of AILE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AILE indicates a rather cheap valuation: AILE is cheaper than 99.29% of the companies listed in the same industry.
AILE is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 2.01
AILE Price Earnings VS Forward Price EarningsAILE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AILE Per share dataAILE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as AILE's earnings are expected to grow with 120.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y189.9%
EPS Next 3Y120.68%

0

5. Dividend

5.1 Amount

AILE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ILEARNINGENGINES INC

NASDAQ:AILE (12/31/2024, 8:06:57 PM)

After market: 0.315 -0.1 (-25%)

0.42

-0.29 (-40.59%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-13 2024-08-13/bmo
Earnings (Next)N/A N/A
Inst Owners5.58%
Inst Owner Change-71.88%
Ins Owners73.9%
Ins Owner Change1.09%
Market Cap59.29M
Analysts82.5
Price Target19.89 (4635.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-666.67%
Min EPS beat(2)-884.31%
Max EPS beat(2)-449.02%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.37%
Min Revenue beat(2)2.15%
Max Revenue beat(2)2.59%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-535.9%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.77%
Revenue NY rev (3m)0.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.01
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 20.28
P/tB 20.28
EV/EBITDA N/A
EPS(TTM)-2.42
EYN/A
EPS(NY)0.21
Fwd EY49.79%
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS2.66
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -219.5%
ROE -11766.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.68%
FCFM N/A
ROA(3y)6.68%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.9%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover2.4
Health
Industry RankSector Rank
Debt/Equity 20.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.4
Quick Ratio 3.4
Altman-Z -1.68
F-Score3
WACC11.22%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-138.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-381.07%
EPS Next Y-3773.81%
EPS Next 2Y189.9%
EPS Next 3Y120.68%
EPS Next 5YN/A
Revenue 1Y (TTM)36.04%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year32.01%
Revenue Next 2Y28.81%
Revenue Next 3Y27.23%
Revenue Next 5YN/A
EBIT growth 1Y59.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year46.37%
EBIT Next 3Y50.95%
EBIT Next 5YN/A
FCF growth 1Y-81.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-80.77%
OCF growth 3YN/A
OCF growth 5YN/A